Article ID Journal Published Year Pages File Type
8829076 Prostate International 2017 9 Pages PDF
Abstract
Metabolomics of seminal plasma in vitro may assist urologists with diagnosis and monitoring of either low or intermediate grade prostate cancer. Less clinical benefit may be observed for high-risk patients. Further investigation in active surveillance cohorts, and/or in combination with in vivo magnetic resonance spectroscopic imaging may further optimize localized prostate cancer outcomes.
Related Topics
Health Sciences Medicine and Dentistry Urology
Authors
, , , , , , , ,